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CHAPTER ONE
INTRODUCTION
Evolution and Genetic Regulation
Even though different vertebrate species look quite diverse in their juvenile and
adult forms, they all begin as a single fertilized egg and use similar developmental
processes and genes to reach their mature state, which can be seen from comparisons of
zebrafish to humans. There are early structural similarities among most vertebrate
embryos during certain stages, including the presence of a head, pharyngeal arches, and a
tail. Many of these early structures seem to be conserved among a variety of species, and
it is the differential regulation of genetic networks that helps specific tissues of each
organism differentiate according to evolutionarily and anatomically integrated patterns of
gene expression (Gilbert, 2010). Particular genes are turned on and off at the appropriate
place and time in development to regulate downstream targets and ensure the proper
development of tissues for that particular organism. From the use of HOX genes in early
developmental processes, to Netrins in axon guidance, many of these genetic networks
are conserved throughout evolution (Manzanares et al., 2000, Rajasekharan et al., 2009).
Even though organisms are constantly evolving in part due to the mutations that are
randomly occurring in their genome, it makes sense that the amino acid sequence of the
coding region of genes are highly conserved in order to maintain protein function
(Bejerano et al., 2004; Pruitt K, 2009). It is more interesting that cis elements associated
closely with genes tend to be functionally conserved through evolution, although relative
1
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position and location in relation to the transcriptional start site appear to vary. This has
led modern biology to focus on the evolution and function of these putative cis regulatory
regions (Maston et al., 2006; ENCODE Project Consortium, 2012). The conservation of
these non-coding sequences over evolution suggests that they are not altered because they
play an important role for the fitness of the organism, particularly in the regulation of the
genome (Woolfe et al., 2005). Appropriate genetic regulation allows for normal cell
growth, but if this process is interrupted it can have detrimental effects on the organism.
In order to understand the components of this regulation it is necessary to identify the
transcription factors essential for the transcriptional regulation. The presence of these
regulatory proteins can accelerate or inhibit the rate of transcription by binding to DNA,
which affects the amount of mRNA produced by the gene (Spitz and Furlong, 2012;
Alberts, 2007). These transcription factors can bind upstream, downstream, near, or far
from the transcriptional start site of a gene because it is the sequence of nucleotides that
determine whether it is capable of binding (Palstra, 2012). The binding of these
transcription factors emphasizes the necessity of organisms to conserve the function of
non-coding portions of the genome based on their role in gene regulation.
Cartilage and Collagens
The requirement for abundant cartilage in a vast number of processes in vertebrate
species suggests the genetic regulation of the genes critical for its formation is
particularly important. Cartilage is a connective tissue evolved to be a support structure
for organisms that also provides flexibility during movement. The elasticity of this tissue
is essential in articular surfaces to support the movement of adjacent bones, in the
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intervertebral discs to cushion the force and strain of the vertebrae, and the ear of mature
animals (Fox et al., 2009; Roberts et al., 2006). Musculoskeletal issues, such as back pain
caused by intervertebral disc degeneration and degradation of joint cartilage and
osteoarthristis, can naturally develop as an individual ages due to wear and tear on the
body. These conditions are becoming more prevalent and leading to a major healthcare
concern in society (Le Maitre, 2007; Freemont, 2009; Goldring, 2012).
Cartilage also has a significant role in the developing embryo because the
endochondral bones that form many parts of the skeleton, like the lower jaw structure of
gnathostomes, are initially composed of cartilage and will provide the framework for
future bone formation (Kuratani, 2005; Kimmel et al., 1998). The differentiated cartilage
cells, called chondrocytes, secrete extracellular matrix representative of cartilage. When
the ossification process begins the chondrocytes undergo hypertrophy and a change in
transcription factor regulation, which will begin the process of calcification of the
chondrocytes and the mineralization of the matrix to form the skeleton (Mackie et al,
2008; Vega et al., 2004). For example, it is the initial configuration of the cartilage that
lays the framework for the lower jaw. This structure is neural crest derived and these cells
migrate from the midbrain and hindbrain region into the pharyngeal arches to form the
craniofacial cartilage, and eventually the bony lower jaw (Minoux and Rijli, 2010; Knight
et al., 2006). This process shows that the tightly regulated spatiotemporal expression of
transcription factors is not only important for the initial differentiation of chondrocytes,
but also continues to play a role in the endochondral ossification process (Ding et al.,
2012; Yang and Karsenty, 2002; Gilbert, 2010).
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Cartilage is mainly composed of an extracellular matrix of collagen and
proteoglycans, which is secreted from proliferating chondrocytes (Gao et al., 2014).
Collagen is an abundant fibrillar protein composed of a triple helix repeat, which can then
link with other collagen molecules in the extracellular matrix (Exposito et al., 2010;
Kadler, 1996). There are twenty-eight different collagen types that are present in a wide
array of tissues including skin, eye, muscle, and cartilage; of these collagen types it is the
type II collagen α1 (COL2A1) gene that is crucial in the cartilage, notochord,
intervertebral disc, and vitreous humor of the eye (Cheah et al., 1991; Alberts et al.,
2007). Mutations to this gene can lead to congenital birth defects including
Achondrogenesis, Stickler syndrome, and Spondyloperpheral dysplasia, and the
detrimental results are characterized by spinal or skeletal deformities, hearing
irregularities, or ocular abnormalities (Winterpacht et al., 1993; Brown et al., 1992;
Kuivaniemi et al., 1991).
Zebrafish have two orthologues of col2a1, referred to as col2a1a and col2a1b.
Following the sequence analysis of the zebrafish homologues, our laboratory has shown
overlapping expression patterns in the perichondrium of cartilage, but only col2a1a was
expressed in the chondrocytes based on in situ hybridization (Dale and Topczewski,
2011). Our laboratory focuses on col2a1a because of this expression in the chondrocytes
and perichondrium of the craniofacial cartilage and the notochord. The goal of our
research is to understand the transcriptional regulation of the zebrafish orthologue col2a1
in order to elucidate the components required for col2a1a expression. Studying the
fundamental aspects of col2a1a transcriptional regulation will provide us with a basic
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understanding of how this evolutionary conserved and critical vertebrate gene functions.
Understanding the transcription factors that determine its expression and the tissue
specific activity of our identified enhancer element may lead to novel ways to initiate
transcription in areas of deteriorating cartilage. By having a minimal regulatory element
that can initiate transcription only in specific cell types will have implications for future
research in the fields of synthetic biology and gene therapy.
There are transcription factors that have already been shown to play an important
role in chondrogenesis, including Sox9 (Yang and Karsenty, 2002; Ng et al., 1997; Yan
et al., 2005). The mouse knockout of Sox9 results in a deficiency of cartilage and bone,
to further emphasize the importance of the transcription factor in early development
(Akiyama et al., 2002). Morpholino injections that target sox9a in zebrafish embryos also
produce zebrafish with disrupted and/or lost craniofacial cartilage structures, similar to
what is observed in mice (Yan et al., 2002). The injection of these targeted morpholinos
was also performed by our laboratory to show the reduction of reporter protein levels
specifically in cranial cartilage elements but not in the ear or notochord in our col2a1a
reporter transgenic zebrafish line (Dale and Topczewski, 2011). While it is evident that
Sox9a is an important transcription factor in the regulation of col2a1a, many other
transcription factors certainly contribute to chondrogenesis. For example, Runx2 is a
transcription factor known to be involved in osteoblast differentiation, but it can be
inferred that this transcription factor has another role early in development because of its
presence when chondrocytes begin to form (Otto et al., 1997; Kerney et al., 2007). In
zebrafish, runx2b and runx3 are expressed at high levels as early as 34 hours post
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fertilization which correlates to the development of the craniofacial cartilage; this
spatiotemporal correlation implies the transcription factor could be important for
regulation of col2a1a by binding to the regulatory element (Flores et al., 2006). These
transcription factors are present at the correct time and place for cartilage formation, but
it is most likely Runx2 that is responsible for this expression based on previous research
(Ding et al., 2012; Flores et al., 2006). Similar to sox9a, the injection of antisense
morpholinos for Runx proteins results in craniofacial deformities (Flores et al., 2006).
Continued research of this transcription factor family will continue to enrich our
knowledge of their different roles in the development of cartilage and the endochondral
ossification process. The Sox and Runx transcription factors are also known to interact
with the Ets family of transcription factors, a large class of DNA binding proteins. Fli1 is
a member of the ERG subfamily of Ets family of transcription factors. Yeast two-hybid
interactions have demonstrated its interactions with Sox proteins (Deramaudt et al.,
2001). Interestingly, Fli1 and Runx1 proteins have been confirmed to bind by
immunoaffinity studies and transcriptional reporter assays (Huang et al., 2009). The
interplay of these transcription factor proteins is particularly interesting because ERG is
shown to have a role in cartilage differentiation and development (Dhordain et al., 1995;
Iwamoto et al., 2001). While these transcription factors are known to play a significant
role in cartilage development, our research hopes to identify whether these proteins are
binding to the critical regulatory element of col2a1a.

7
Zebrafish Model Organism
Our laboratory is interested in studying the fundamental aspects of col2a1
transcriptional regulation utilizing Danio rerio, commonly known as the zebrafish.
Zebrafish are an excellent vertebrate model organism for our research because of their
transparent embryo and reproductive capabilities (Westerfield, 2000). This transparency
allows us to view development of the zebrafish without disrupting the embryo or mother,
as well as visualize the presence of the fluorescent proteins using standard microscopy
techniques. Their large clutch size and rapid development is also an advantage compared
to other vertebrate model organisms. While these are beneficial for our research, it is the
conservation of vertebrate signaling pathways that make zebrafish an ideal model
organism for studying developmental pathways (Dooley and Zon, 2000). The ability to
easily produce transgenic zebrafish will allow us to characterize the upstream regulatory
element of collagen.
Transcriptional Regulation of col2a1a
A 182 bp regulatory element was identified in the first intron of the mouse Col2a1
gene, and could drive expression of a reporter gene in chondrocytes (Zhou et al, 1995).
Interestingly, the characterized mouse enhancer is quite weak and there have been
suggestions in the field that there are other stronger enhancers elsewhere. Subsequently,
our laboratory identified a 360 bp regulatory region in zebrafish as the region critical for
cartilage, ear, and notochord expression of col2a1a, as determined by its ability to
express enhanced green fluorescent protein (EGFP) at the proper time and place (Dale
and Topczewski, 2011). The regulatory element important for this expression, referred to
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as R2, was identified using comparative genomics of four distantly related teleost fish.
Twelve kilobases (kb) of the zebrafish, medaka, fugu, and stickleback genome
surrounding the transcriptional start site were compared, and four highly conserved
sequences were discovered. When these conserved regions were placed upstream of a
reporter gene to drive expression, only the R2 region drove EGFP expression in the
appropriate tissues. The 360 bp regulatory region was approximately -1.7kb upstream of
the transcriptional start site of col2a1a on chromosome 8, as indicated by the schematic
in Figure 1. As previously published, the plasmid containing the R2 regulatory element
driving expression of EGFP can recapitulate most of the endogenous expression of
col2a1a, with the presence of this fluorescent protein in the cartilage, ear, and notochord.
The goal of our research was to determine what region of R2 was responsible for
initiating transcription, and by isolating this portion of the regulatory region for col2a1a
we could begin to infer the mechanisms of its regulation. Deletion analysis of the R2
regulatory region has been performed testing six 60 bp units designated as A through F,
which allowed us to identify the critical region of the regulatory fragment that can drive
expression of col2a1a. Gateway Cloning, zebrafish transgenesis, and fluorescence
microscopy were used to determine which section of the R2 region was critical for the
expression of col2a1a (Kawakami, 2004). Subsequently, our aim was to identify tissue
specificity within the R2 subunits. Testing segments of the R2 regulatory region in
isolation demonstrated whether these individual fragments were responsible for the
specific expression in the cartilage, ear, or notochord. This process allowed for an
inference as to whether the reporter protein expression could be activated specifically in
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different tissues. The last step was to determine what transcription factors may be
required for the expression pattern in each specific tissue. The isolation of a minimal
regulatory region was crucial in the identification of transcription factor binding sites that
were necessary for expression in that specific tissue. In silico analysis using comparative
genomics to assess the sequences of distantly related teleosts identified highly conserved
sequences, and potential transcription factor binding sites of interest. The importance of
these putative transcription factor binding sites were determined using site-directed
mutagenesis of the identified sequences. This process investigated of the interactions
between the DNA sequence in the regulatory region and the transcription factors that
were bound to allow for transcriptional initiation.

In

particular

if

the

smaller

regulatory units were crucial for expression in different tissues of the zebrafish, we
could begin to identify the transcription factors and their networks that were essential for
expression in the different units of the regulatory region.

CHAPTER TWO
MATERIALS AND METHODS
Construction of Minimized R2 Entry Plasmids
Amplification of the R2 minimized plasmids
The homologous recombination technology of the Multisite Gateway vector
system was used to construct the expression plasmids containing the dissected regulatory
elements (Petersen and Stowers, 2011). The primers used for the amplification of the
minimized R2 units were derived from the complementary sequence of the regulatory
element. Additional sequences, referred to as attB sequences, were added to the flanking
5’ end of the primers to subsequently assist with their recombination into the pDONR
vectors. The PCR primer sets used for the amplifications are listed below.
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Table 1. Primers for isolation of R2 minimized plasmids
Regulatory
Elements
AB

BC

CD

DE

EF

D

E

D-E1

D2-E

D2-E1

Forward Primer

Reverse Primer

GGGGACAACTTTGTATAG
AAAAGTTGCTGCCCTCTG
ACACCTGATGCCAATTGC
GGGGACAACTTTGTATAG
AAAAGTTGATCCAATGGC
CAGGCCCCTCATCATC
GGGGACAACTTTGTATAG
AAAAGTTGCTGAGCCTCT
CCGTGTTCTCCTCATCC
GGGGACAACTTTGTATAG
AAAAGTTGCTGCGGCTCT
CTTCTCCCCCACTGCC
GGGGACAACTTTGTATAG
AAAAGTTGCTGCCGCATT
GTGTGTGTGTCTTACAG
GGGGACAACTTTGTATAG
AAAAGTTGCTGCGGCTCT
CTTCTCCCCCACTGCC
GGGGACAACTTTGTATAG
AAAAGTTGCTGCCGCATT
GTGTGTGTGTCTTACAG
GGGGACAACTTTGTATAG
AAAAGTTGCTGCGGCTCT
CTTCTCCCCCACTGCC
GGGGACAACTTTGTATAG
AAAAGTTGAGTCTCTCAC
ATTCCTCAGGTCTGC
GGGGACAACTTTGTATAG
AAAAGTTGAGTCTCTCAC
ATTCCTCAGGTCTGC

GGGGACTGCTTTTTTGTA
CAAACTTGCCAGGGGTG
TGTAGGGTGGCTGGG
GGGGACTGCTTTTTTGTA
CAAACTTGCGGGTGTGG
ATGGAGGGAGAGTGCG
GGGGACTGCTTTTTTGTA
CAAACTTGCTCTGTGTGC
AGACCTGAGGAATGTG
GGGGACTGCTTTTTTGTA
CAAACTTGCGTGTGTGTG
TCCGAAATGAGCCC
GGGGACTGCTTTTTTGTA
CAAACTTGCAGGGATAT
GTGTATGTGTGTGTACG
GGGGACTGCTTTTTTGTA
CAAACTTGCTCTGTGTGC
AGACCTGAGGAATGTG
GGGGACTGCTTTTTTGTA
CAAACTTGCGTGTGTGTG
TCCGAAATGAGCCC
GGGGACTGCTTTTTTGTA
CAAACTTGAGTGCTCTGT
AAGACACAC
GGGGACTGCTTTTTTGTA
CAAACTTGCGTGTGTGTG
TCCGAAATGAGCCC
GGGGACTGCTTTTTTGTA
CAAACTTGAGTGCTCTGT
AAGACACAC

The previously published plasmid in Dale and Topczewski 2011 containing the
R2 region in the 5’-entry vector was used to amplify the subunits of R2 (A-F). The PCR
reactions contained dNTPS (200 μM each), 20 μl I- Buffer, 10 ng DNA, 2 U iProof DNA
polymerase (BioRad), and forward and reverse primers (1 μM each) for the desired
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subunit. The PCR program used for the amplification of the attB-flanked product is
detailed below.
Step 1
98°C
1 min
Step 2
98°C
45 sec
Step 3
60°C
45 sec
Step 4
72°C
30 sec
Repeat Step 2-4 x35 times
Step 5
72°C
10 min
Step 6
4°C
10 min
Step 7
15°C
∞
In order to verify the amplification of the correct sequence, agarose gel
electrophoresis was performed to confirm the size of the PCR product. The confirmed
band length was cut from the agarose gel, and the Zymoclean Gel DNA Recovery Kit
was used to purify the DNA. Three volumes of the agarose dissolving buffer were added
to the gel fragment and incubated at 50°C to liquefy the solid gel to release the desired
DNA fragment. The solution was subsequently centrifuged in a column to remove the
agarose, while the DNA remained bound to the filter. The DNA binding filter was rinsed
with a DNA wash buffer, and then the purified DNA was eluted. This process isolated,
amplified, and purified the R2 minimized units with the flanking attB sequences.
Insertion of amplified sequence in plasmid
The purified PCR products for the subunits of R2 (AB, BC, CD, DE, EF, D, E, DE1, D2-E, D2-E1) had the attB sites required for recombination into the 5’- entry vector
in a Multisite Gateway BP reaction. A mixture with 150 ng of the PCR product, 150 ng
of the pDONR4-1 vector, TE Buffer, and 2 μl of BP clonase enzyme was made and
incubated overnight at room temperature. The following day the reaction was terminated
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by the addition of 1 μl of proteinase K to the reaction. The pDONR4-1 vector had a ccdB
gene that eliminated potential bacterial cells that contained the original pDONR plasmid,
and did not recombine out the ccdB gene. This gene is recombined out of the vector if our
sequences are successfully integrated. The homologous sequences between the pDONR
vector and the attB sites on the PCR product allowed the recombination of the PCR
product into the 5’-entry vector, which removed the ccdB gene. Bacterial cells that
contained the entry vector with the appropriate insert proliferated, while those cells with
the original ccdB gene were destroyed. The plasmid was added to chilled TOP10 One
Shot chemical competent cells (Invitrogen), which was set on ice for 30 minutes. These
cells were heat-shocked at 42°C for 90 seconds to allow for plasmid uptake into the
bacterial cell. Super Optimal Broth with Catabolite Repression (SOC) medium was added
to the cells and provided nutrients for the replication of bacterial cells, and in turn
produced copies of the desired vector. After an hour in a 37°C shaking incubator, the
bacterial cultures were centrifuged and the pellet was resuspended in 125 μl of the SOC
medium. This concentrated bacterial culture was plated on a kanamycin antibiotic plate
and grown overnight at 37°C to selectively allow growth of bacteria that had taken up the
desired plasmid. The 5’-entry plasmids had a kanamycin resistance gene, so bacterial
cells with the entry plasmids were resistant to this antibiotic. For our transformation,
kanamycin eliminated the bacterial cells without our desired plasmid. The individual
colonies on the agar plates were instances of bacterial cells with the minimized R2 units
in the 5’-entry plasmid, which provided antibiotic resistance.
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Purification of plasmid DNA from transformation
The Zyppy Plasmid Miniprep Kit (Zymo Research) was used for the purification
of the 5’-entry plasmids, which separated the plasmids from the components of the
bacterial cell. At least five individual colonies from each transformation plate were
chosen for inoculum of 2 ml liquid cultures, which were grown for 6-16 hours in a
shaking incubator at 37°C. At least six hundred microliters of each culture were placed in
an eppendorf tube and lysis buffer was added. The bacterial cells were lysed to release
the plasmids into the supernatant, while the remnants of the bacterial cells formed a
precipitate. The addition of refrigerated neutralization buffer ceased the reaction.
Subsequently the mixture was spun down for the compression of the cellular components
into a pellet, while the supernatant was easily separated into a spin-column. The
replicated plasmid in the supernatant was bound to the filter, while the remaining liquid
was drained through the spin column. The filter on the spin column was rinsed with wash
buffers to be certain only the plasmid was bound to the filter, and then the plasmids were
released with the addition of an elution buffer and subsequent centrifugation. The final
product of the Zyppy Plasmid Miniprep Kit was approximately 30 μl of the 5’-entry
plasmid with the minimized R2 units.
Confirmation of accurate plasmid
The miniprep culture with the correct product was initially confirmed with the
digestion of the plasmid with restriction enzymes. A mixture that included 400 ng of the
plasmid, 10 units of SacI (New England Biolabs), 2 μl of Buffer 1, and 2 μl 10x BSA
were incubated to allow for the plasmid to be cut at two sites. Gel electrophoresis
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confirmed positive colonies that had the expected bands for the AB-EF plasmids. Each
was predicted to give bands of 2377 bp and 387 bp on a 1% agarose gel stained with
ethidium bromide. The correct band length on the agarose gel was visualized under
ultraviolet light, and at least five hundred nanograms of the miniprep product were sent to
GeneWiz Inc (South Plainfield, NJ) to be sequenced using the M13 Forward and M13
Reverse primers. The following day the sequencing results were downloaded from
GeneWiz, where they were analyzed using the bioinformatics tool Geneious (Biomatters
Ltd.), to compare the sequenced results to the original R2 regulatory region sequence.
The program displayed a visualization of the nucleotide sequences of the amplified and
control R2 region, and was an assurance that the appropriate nucleotides were present in
the 5’-entry vector.
Preparation of larger volume of plasmids
Once the sequencing results were confirmed, a greater amount and concentration
of the DNA was accomplished with Zymo Research’s Zyppy Plasmid Maxiprep Kit. A
1:1000 dilution of kanamycin was added to 150 μl of LB broth, and one hundred
microliters of the miniprep culture with the confirmed band length was used as an
inoculum of the broth. The inoculated culture was grown at 37°C overnight in a shaking
incubator. After sixteen hours of incubation, the maxiprep culture was spun down in a
centrifuge at 4700g for twenty minutes, which produced a bacterial pellet. The pellets
were resuspended in 15 mL of buffer, and a lysis buffer was subsequently added. Very
similar to the miniprep kit, the bacterial cells were lysed to release the contents of the
cells, including the plasmid DNA, into the supernatant. The neutralization buffer was

16
added and the mixture was stored on ice for 10 minutes. The separation of the precipitate
eliminated the components of the bacterial cell, but left the plasmids in the supernatant.
Using the vacuum manifold method, the column attached to the vacuum removed the
supernatant and left the plasmids attached to the filter. The column was rinsed with a
wash buffer, which eliminated any residues that inadvertently stuck to the filter. The
addition of three milliliters of the Zyppy Elution Buffer and centrifugation of the column
released the plasmid. The final product of the maxiprep procedure was a higher
concentration of the 5’-entry plasmids with the minimized R2 units.
Construction of mutated putative transcription factor binding sites
In a process similar to the identification of R2, comparative genomics was utilized
to determine which nucleotides should be altered using site directed mutagenesis. By
comparing individual nucleotides in the DE region of zebrafish, stickleback, medaka, and
tetradon, highly conserved sequences were identified. These sequences were potential
transcription factor binding sites, which happened to correlate to the Ets, Runx, and Sox
families of transcription factors. Site-directed mutagenesis by PCR changed the specific
nucleotides that were important for the binding of these transcription factors. The PCR
primers contained the altered nucleotides within the DE sequence and amplified outward,
which copied the entire entry vector. These primers were also phosphorylated at the 5’
end, which was essential for the ligation of the vector. A mutated vector was created for
each potential transcription factor binding site individually, as well as each of the sites in
parallel with each other. The addition of DpnI restriction enzyme (New England Biolabs)
digested the entry vectors that were methylated. A digest with this restriction enzyme cut
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the original methylated DE vector, while the new un-methylated mutated vectors created
via PCR remained intact. Gel electrophoresis confirmed the correct band length of the
PCR product was 2764 base pairs. Pending correct results, the PCR product was purified
with Zymo Research’s Zyppy DNA Clean and Concentrator Kit. The Quick Ligation Kit
(New England Biolabs) was subsequently used in the recircularization of the
phosphorylated ends of the PCR product. The combination of the PCR product, deionized
water, 10 μl 2x Buffer, and 1 μl Quick Ligase was incubated at room temperature for 10
minutes. The reaction was put on ice until the standard transformation procedure was
completed with kanamycin antibiotic plates. Following the transformation, cultures were
started from individual colonies and plasmids were extracted with the Zyppy Plasmid
Miniprep Kit. The isolated plasmids were digested with SacI (New England Biolabs) to
confirm the correct band lengths were 2377 bp and 387 bp. The plasmids with the
appropriate band lengths were sent out for sequencing with an M13 forward primer.
When the results confirmed the sequence was correctly mutated, a maxiprep culture was
prepared using the miniprep culture as the inoculum.
Generation and Analysis of Minimized R2 Reporter Transgenic Zebrafish
Construction of destination vector
The final expression vector was formed from the recombination of three entry
vectors into the final destination vector. The dissected R2 regulatory region was placed in
5’-entry vector as described above. An adenovirus derived E1b transcriptional initiator
with a Carp TATA-box were used as a minimal promoter was placed in the middle-entry
vector. An enhanced green fluorescent protein (EGFP) gene was placed in the 3’-entry
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vector, and it produced the reporter protein that was visualized by fluorescent
microscopy. The 5’-entry vectors were constructed in the Dale laboratory; the middleentry and 3’-entry plasmids were obtained from the Topczewski laboratory at Lurie
Children’s Research Center and used in previous experiments (Dale and Topczewski
2011). Ten fentomoles of each entry plasmid, 20 fentomoles of the destination vector,
tris-EDTA buffer, and 2 μl of LR clonase were added together for the LR reaction and
incubated at room temperature overnight. The addition of the LR clonase enzyme assisted
with the recombination of the entry vectors into the appropriate orientation in the final
destination vector; the reaction was based on the attR sequences present in the plasmids.
Proteinase K was added to the reaction and placed at 37°C for 15 minutes, which
terminated the reaction by destroying the reaction enzymes. The final expression vector
contained the minimized R2 regulatory unit, which drove expression of the EGFP
reporter protein. The final expression vector was transformed into Top10 chemical
competent bacterial cells (Invitrogen) by heat-shock, and the plasmids penetrated the cell
wall of the bacterial cells. Five hundred microliters of LB broth was added to the
transformed cells, and placed in a 37°C shaking incubator for one hour, which aided in
the division of the bacterial cells and therefore generation of the transgenic plasmid. The
bacterial culture was centrifuged into a pellet and resuspended with 125 μl of the culture,
which gave a concentrated bacterial culture. The transformation mixture was spread on
an ampicillin antibiotic plate and incubated overnight to selectively permit growth of the
bacterial cells that took up the expression plasmid. The pDest final destination vector had
an ampicillin resistant gene, which was passed onto the bacterial cells that took up the
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plasmid. The colonies on the agar plates were the reproduction of individual cells that
contained the expression vector with antibiotic resistance.
The procedures used for the isolation of the entry vector plasmids were repeated
for the production of a high concentration of the final expression vector. The Zyppy
Miniprep Kit isolated the expression vector from the miniprep cultures with ampicillin.
The plasmids were cut at two sites when digested with SacI (New England Biolabs), and
the expected band lengths for gel electrophoresis were 1700 bp and 3500 bp. The
miniprep culture with the correct digest was used for the inoculation of 150 mL of LB
broth with ampicillin, and grown overnight at 37°C in a shaking incubator. Zymo
Research’s Zyppy Maxiprep Kit, was used to extract the plasmid DNA, and provided 30
μl of the final expression vector. This process was also done for the generation of the R2
mutagenesis enhancer elements as well. An LR reaction inserted the mutated region, the
E1b-TATA sequence, and the EGFP reporter gene into the pDestTol2 vector. The LR
reaction was transformed and placed on ampicillin plates, and the Zyppy Plasmid
Miniprep Kit procedure was performed on their cultures to isolate the DNA. The
plasmids were digested with SacI (New England Biolab), and confirmed the band lengths
were 3512 bp and 1785 bp. The miniprep culture was used to inoculate a maxiprep
culture, and a larger volume of the plasmid was isolated with the Zyppy Plasmid
Maxiprep Kit
Zebrafish embryo microinjections
The DNA plasmids were injected into embryos at the one-cell stage; the
expectation was that the transgenic plasmid would be present in each of the dividing cells

20
of the developing embryo. The final expression plasmids were diluted to 80 ng/μl of
DNA, and added to 1 μl of 4x Danio solution, 1 μl of transposase, and 1 μl of phenol red.
The transposase assisted with the integration of the reporter sequence into the zebrafish
genome, which aided in the establishment of a stable line for the zebrafish. Phenol red
was essential for the visualization of the injection solution into the zebrafish embryos.
Capillary tubes were pulled and formed a sharp needle, which penetrated the chorion and
embryo for the injection process. The injection solution was loaded into the needles and
placed in a microinjector. The zebrafish embryos were organized into rows on agar
plates, and microscopes were used to observe the insertion of the needle into the embryo
for the injection. Even though the EGFP expression pattern was visualized in the transient
zebrafish in a mosaic fashion, a stable line was established in the next generation with the
transposition of the transgenic sequence into the germ line cells. The zebrafish that were
positive for the EGFP reporter protein were grown to adulthood, and then crossed with
wild-type zebrafish. The second generation with EGFP in the tissues provided a
confirmation of the results and displayed a clear expression pattern of the reporter
protein.
Imaging and analysis of transgenic zebrafish lines.
Following the injections, the zebrafish were prepared for fixation at 5 days post
fertilization (dpf). Ice was added to the water in the petri dish containing the zebrafish,
and the larval fish were subsequently collected in eppendorf tubes. The water was
removed from the eppendorf tubes and replaced with 4% paraformaldehyde (PFA)
(Sigma) in phosphate buffered saline (PBS). The zebrafish in PFA solution were stored
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overnight on a compact rocker in a 4°C laboratory refrigerator. After about 16 hours in
the cold, the 4% PFA solution was removed from the eppendorf tubes and replaced with
PBS supplemented with 0.02% Triton-X 100 (PBS-TX) and placed on a laboratory
rocker for 15 minutes. The PBS-TX was removed and replaced with fresh PBS-TX
solution at least 5 times, which rinsed and removed the remainder of the PFA. The rinsed
zebrafish were ready for scoring, and stored at 4°C when not being examined.
The zebrafish tissues were inspected for EGFP expression under the fluorescent
microscope. A scoring sheet was designed for the inventory of the EGFP expression in
the tissues of the zebrafish, and one sheet was dedicated to each construct injected from
the clutch of embryos. The top half of the scoring sheet contained images of the lateral
view and ventral view of a zebrafish and focused on their anatomy (Haffter et. al, 1996).
These images were used as the basis of the identification of expression in the tissues, and
they were also marked for expression in unexpected tissues. The bottom half of the
scoring sheet was a table used to tally the expression pattern of the zebrafish, particularly
in the expected tissues. The table consisted of columns for expression in the notochord,
craniofacial cartilage, ear, heart, skin, muscle, and other tissues. Based on an examination
of each zebrafish under the fluorescent microscope, marks were made under the
appropriate column when EGFP was present in particular tissues. The scoring permitted a
calculation of the total number of zebrafish with EGFP in each of the tissues, which
determined the percentage of fish that expressed the reporter gene. The zebrafish were
also mounted on slides, and high quality images were captured with an Olympus
Fluoview 1200 laser-confocal microscope. The images captured were at a 10x
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magnification and a 1:1 aspect ratio with 1024 x 1024 resolution. A Z-scan captured a
series of images of the zebrafish at different depths, which allowed for the visualization
of EGFP expression in the various tissue layers. Images of the ventral view of the
zebrafish head displayed the craniofacial cartilage, while the lateral view images revealed
the ear, notochord, and craniofacial cartilage. Each construct was imaged with at least
three fish in the ventral view, as well as a lateral view of three fish from the anterior to
posterior end.
Construction of Transcription Factor Expression Plasmids
Isolation of transcription factor sequences
The construction of the transcription factor expression vector began with the
isolation of the RNA from a zebrafish embryo digest. Thirty-five zebrafish embryos were
euthanized according to our IACUC approved protocol, and placed in a microcentrifuge
tube and measured to determine the total weight. One milliliter of Invitrogen TRIzol was
added per 50 mg of tissue, and the solution was homogenized with a syringe and spun
down for one minute. An equivalent volume of ethanol was added to homogenate, and
the mixture was loaded onto the spin column and spun down for one minute. Four
hundred microliters of Direct-zol RNA pre-wash from Zymo was added to the column
and spun down for one minute. The flow through was discarded and this process was
repeated. Two hundred microliters of the RNA Wash Buffer was added to the column
and the flow-through was once again discarded. The column was transferred to a new
microcentrifuge tube, and 30 μl DNase/RNase-free water were added to the column and
spun down for the final RNA product. The complementary DNA sequences of the
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transcription factors were created from the zebrafish RNA using Life Technologies’
Superscript III Reverse Transcriptase Kit. The total RNA, primers, a dNTP mix, and
deionized water were added to a nuclease-free microcentrifuge tube and heated for 5 min
at 65°C, followed by an incubation for one minute at 4°C. First strand buffer, 0.1 DTT,
and superscript III reverse transcriptase were added to each microcentrifuge tube and
incubated at 25°C for 5 min, 50°C for 60 min, and 70°C for 15 min. The addition of
RNase H and an incubation of 37°C for 20 minutes degraded the RNA, which left all the
complementary DNA strands, including the sequences for our transcription factors.
Primers were designed to isolate the sequence for the specific transcription factors from
the total zebrafish cDNA.
Table 2. Primers for isolation of transcription factors
Transcription
Forward Primer
Factors
Ets1
Sox9a
Runx3

CGTTTGAATGCGTGACCAT
GACGGC
CCATCTACGGTGTTACCAT
GAATC
CTG TAG CCT ACT CAA
CCA ACT G

Reverse Primer

GCAGGATTTATCCGTCAGG
AGCTCC
CATTCAGGCGTGCTCATGG
TCTGG
ATC ATG CGC AAC TCT TCT
GGT C

A PCR reaction using this cDNA, 1.25 μl (1μM) designated primers (Table 2), 10 μl
iProof Buffer, 1 μl (200 μM) dNTPs, 0.5 μl (1 U) iProof polymerase, and deionized water
were used to isolate the desired transcription factor sequence with the following protocol:
Step 1
98°C
1 min
Step 2
98°C
30 sec
Step 3
60°C
30 sec
Step 4
72°C
45 sec
Repeat Step 2-4 x34 times
Step 5
72°C
10 min
Step 6
4°C
10 min
Step
15°C
∞
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The product of this PCR reaction was run on a 1% low melt agarose gel, and
subsequently separated and purified using the Zymoclean Gel DNA Recovery Kit. The
isolated DNA was used in a second PCR reaction, which amplified the same transcription
factor sequence with different primers that contained attB sites (Table 3). The PCR
product was again run on a 1% low melt gel, and the correct bands were once again
separated using Zymoclean Gel DNA Recovery Kit.
Table 3. Primers with attB sites for isolation of transcription factors
Transcription
Forward Primer
Reverse Primer
Factors
Ets1*
Sox9a*
Runx3*
Fli1a

GGGGACAAGTTTGTACAAAAA
AGCAGGCTAGCGTTTGAATGC
GTGACCATGACGGC
GGGGACAAGTTTGTACAAAAA
AGCAGGCTAGCCATCTACGGT
GTTACCATGAATC
GGGGACAAGTTTGTACAAAAA
AGCAGGCTAGTTGTGATGCAT
ATTCCCGTAGACC
GGGGACAAGTTTGTACAAAAA
AGCAGGCTAGTTGTGATGCAT
ATTCCCGTAGACC

GGGGACCACTTTGTACAAGAA
AGCTGGGTAGCAGGATTTATC
CGTCAGGAGCTCC
GGGGACCACTTTGTACAAGAA
AGCTGGGTACATTCAGGCGTG
CTCATGGTCTGG
GGGGACCACTTTGTACAAGAA
AGCTGGGTATCTTAGTACGGC
CTCCAGACAGAC
GGGGACCACTTTGTACAA
GAAAGCTGGGTATCTTAGTAC
GGCCTCCAGACAGAC

Transcription factor sequence inserted into middle-entry vector
Using Gateway Technology, the isolated DNA sequence of the transcription
factors were inserted into the middle-entry vector using a BP reaction. The gel purified
PCR products had the appropriate attB sites for recombination into the middle-entry
vector. A mixture of 150 ng of the PCR product, 150 ng of the pDONR 221 vector, TE
Buffer, and 1 μl of BP clonase enzyme were added and incubated at room temperature
overnight. The following day 1 μl of proteinase K was added to terminate the reaction
with a 15 minute incubation at 37°C. This reaction generated middle-entry vectors with
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the newly inserted PCR product, which was then transformed into bacterial cells. The
middle-entry plasmids had a kanamycin resistance gene, therefore the colonies on the
antibiotic- agar plates were indicative of bacterial cells with the desired plasmid.
Isolation of middle-entry plasmids
The Zyppy Plasmid Miniprep Kit standard procedure isolated the middle-entry
plasmids for the DNA sequence of sox9a, ets1, and runx3. The middle-entry vector for
ets1 was digested with SacI (New England Biolabs) for the expected band sizes of 29998
bp and 585 bp. The expected bands for sox9a when digested with ApaLI (Fermentas)
were 2295 bp and 1671 bp. The middle-entry vector for runx3 was digested with HincII
(New England Biolabs), and the expected band lengths were 3154 bp and 675 bp. The
bands that travel the correct distance according to the ladder had the potential to be
accurate, so they were sent out for sequencing. Five hundred nanograms of the plasmids
were sent out to GeneWiz for sequencing with the M13 forward and M13 reverse primers
to determine the accuracy of the sequences. When the sequence accuracy was confirmed,
100 μl of the corresponding miniprep culture was used to inoculate 150 mL of LB broth
with kanamycin. Standard maxiprep procedures with the Zyppy Plasmid Maxiprep Kit
isolated a large volume of the desired plasmid.
Transcription factor expression vectors
Gateway technology was once again employed to insert the transcription factor
sequence into the final expression vector with homologous recombination. A mixture of
150 ng of the middle-entry vector with the transcription factor sequence, 150 ng of the
pCSDest vector, TE Buffer, and 1 μl LR clonase enzyme were added together and
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incubated at room temperature overnight. The following day, 1 μl of proteinase K was
added to the reaction with a subsequent 15-minute incubation at 37°C to terminate the
reaction. The expression vector was transformed into bacterial cells, and the ampicillin
plates were incubated overnight at 37°C. Individual, isolated colonies from the bacterial
plates were used to make 2 mL bacterial cultures and the Zyppy Plasmid Miniprep Kit
was used for the isolation of the plasmids. The plasmids from the miniprep protocol were
digested with various restriction enzymes to check the lengths of the bands. The
expression vector for runx3 was digested with HincII (New England Biolabs), with the
correct band lengths of 3154 bp and 675 bp. A PvuII (New England Biolabs) digested the
expression vector of ets1a, which formed two bands of 3661 bp and 1531 bp. Also, the
expression vector of sox9a was digested with ApaLI (Fermentas), with accurate bands
lengths of 2579 bp, 1750 bp, and 1246 bp. For the DNA with the correct band lengths,
the corresponding miniprep culture was used to inoculate 150 mL of LB broth with
ampicillin. This culture was used for the Zyppy Maxiprep Plasmid Kit and the isolation
of the desired plasmids.
Generate transcription factor mRNA
The transcription factor expression vectors were digested with the appropriate
restriction enzymes, purified with phenol:chloroform, and finally RNA was synthesized
using the mMessage mMachine Kit (Life Technologies). Ten micrograms of the
expression vectors for Runx3, Ets1, and Sox9a were digested with NotI into 100 μl
reactions, and incubated for three hours. After digestion, the volume was brought up to
200 μl with RNA-free water. An equal amount of phenol:chloroform:isoamyl alcohol was
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added to the solution. Each tube was centrifuged at 16,000g for 5 minutes. When the
aqueous layer was recovered, 200 μl of chloroform was added to the solution, centrifuged
again for 3 minutes and repeated. The upper aqueous layer was once again recovered and
the DNA was precipitated with the addition of 20 μl of sodium acetate and 500 μl of
ethanol. This solution was mixed and incubated at 20°C for 30 minutes and subsequently
spun down at 4°C for 20 minutes at 16,000g. The supernatant was discarded and the tube
was left to dry. Five hundred microliters of 70% ethanol was added to the tubes and spun
down at 4°C for 10 minutes at 16,000g. The sample was resuspended with 25 μl of
RNAse free water. Finally, the sample was run on a 1% agarose gel to verify the presence
and accuracy of the results. This process provided the purified transcription factor
expression vectors, but the synthesis of the RNA can be completed with the mMessage
mMachine Kit (Life Technologies). The following solutions were added to an eppendorf
tube and incubated at 37°C for 2 hours: 10 μl 2x NTP/CAP, 2 μl 10x reaction buffer, 1 μg
isolated DNA, 2 μl of the enzyme mix, and RNAse free water if necessary. Any
remaining DNA was eliminated with the addition of 1 μl TURBO DNAse (Ambion),
which was added to each tube and incubated at 37°C for 15 minutes. The RNA product
was purified using NucAway spin column (Ambion), which placed the sample on the
hydrated gel bed and spun the column in a centrifuge at 750g for 2 minutes. This
completed the synthesis of the transcription factor RNA, which was prepared for
microinjections.
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Zebrafish embryo microinjections
The RNA of the transcription factors was injected into the embryos at the one-cell
stage, which was at an earlier stage than the genes endogenous period of transcription.
The transcription factor mRNAs were diluted to 300 ng/μl of RNA, and added to 4x
Danio solution and phenol red. The mixture of transcription factor RNA was injected into
the stable line R2-DE embryos, which would produce the protein and theoretically
initiated transcription of the EGFP reporter gene. The binding of the transcription factors
to the DE region would be confirmed with the presence of the reporter protein prior to
normal expression.
Zebrafish Husbandry
Zebrafish housing and care was maintained as per LeClair et al. (2009) for wildtype and transgenic zebrafish lines in the vertebrate animal care facility at Loyola
University Chicago (Chicago, IL). A natural spawning technique was used to obtain
embryos for these experiments, and they were staged according to Kimmel et al. (1995).
Zebrafish for these experiments were scored based on the morphology labeled by
Kimmel et al. (1995). The protocols and care of the zebrafish were approved by IACUC
of Loyola University Chicago (Chicago, IL).
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CHAPTER THREE
RESULTS
Identification of R2-DE as the col2a1a Regulatory Region
Our laboratory has previously identified a critical zebrafish regulatory sequence
of the col2a1a gene, referred to as R2, allowing for the expression of Col2a1a protein in
the craniofacial cartilage, ear, and notochord utilizing zebrafish transgenic report analysis
(Dale and Topczewski 2011). To identify what segment of the R2 unit is critical for tissue
specificity, we set out to dissect the previously identified sequence. To be able to
compare my work to that of the previous transgenic reporter analysis, I repeated the
original Dale and Topczewski 2011 transient transgenic R2 experiments to demonstrate
my technique was similar to the original work. During my study, the injections completed
with the original R2 transgenic plasmid had EGFP reporter expression in about 30% of
the embryos (Table 4). When compared, there seemed to be no difference in expression
pattern compared to the original work, allowing us to set out to dissect the R2 element.
While the identification of the R2 regulatory element was originally based on its
ability to recapitulate expression in critical tissues, it was also based on a teleost fish
conserved sequence of 360 bp, which could contain many overlapping transcription
factor binding sites. We set out to minimize the R2 regulatory element to determine
exactly which bases of the original 360 are responsible for the transcriptional regulation
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of col2a1a.

To do this we utilized a combination of Gateway cloning, zebrafish

transgenesis, and fluorescence microscopy to identify the critical sequence for gene
expression. The R2 regulatory region was divided into 5 overlapping fragments (AB, BC,
CD, DE, EF), and placed upstream of an EGFP reporter gene. The first 120 bp of the R2
regulatory region, AB, was not able to drive expression of the reporter protein when
examined under the fluorescent microscope (Figure 3). Of the 233 embryos that were
injected and scored at 5 days post fertilization (dpf), none of the juvenile zebrafish
expressed the reporter protein in the craniofacial cartilage and only one EGFP positive
cell was observed in the ear and notochord in one zebrafish, suggesting that zebrafish to
be a statistical outlier when the overall totals were compiled (Table 5). The embryos
injected with the plasmid driven by the BC subunit also lacked expression of the reporter
protein (Figure 4). There were no embryos with expression in the notochord of the 191
embryos injected (Table 6). There were two zebrafish with slight expression in the
craniofacial cartilage and one with expression in the ear, but again this was not
statistically significant. These injections eliminated the first 180 bp of the R2 element
responsible for the majority of col2a1a expression. Of the 150 embryos injected with the
reporter plasmid that was driven by the CD subunit, there was no evident EGFP
expression when examined and scored under the fluorescent microscope (Table 7; Figure
5). EGFP expression was present in all expected tissues of the zebrafish injected with the
DE subunit and recapitulated the original R2 expression pattern seen (Figure 6). Of the
221 total zebrafish embryos injected with the DE construct, about 30% of the zebrafish
expressed the EGFP reporter in the craniofacial cartilage, ear, and notochord (Table 8). I
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also did notice reporter expression in cranial neurons in these transient transgenic lines as
was seen in the original transient R2 element characterization, but this expression was
lost in the stable lines. The results of these DE injections paralleled the expression
patterns of my initial experiments of the entire R2 region. Finally, when the expression of
the reporter plasmid was driven by the EF subunit, there was again no fluorescent seen in
109 of the zebrafish examined and scored (Table 9; Figure 7). Even though the embryos
injected with the CD and EF subunit vectors had no visible fluorescent protein under the
dissecting microscope, when these embryos were imaged using a laser-confocal
microscope, there seemed to be only a faint outline of possible expression in the
craniofacial cartilage. This was interesting because the CD and EF reporter plasmids each
contained half of the DE subunit, which seems sufficient to phenocopy R2 activity in the
desired tissues. Even though the CD region contained the D region, and EF contained the
E region, it was not sufficient to drive expression like the DE region.
To test if either the D or E region could alone drive reporter activity and therefore
be the critical sequence of the regulatory region, the DE regions were split into 60 bp
enhancer fragments regulating the expression of EGFP (Figure 9). Reporter plasmid
expression driven with the R2-D unit did not yield GFP positive tissues in the 44
embryos injected (Table 13). Of the 44 embryos injected with the R2-E unit only 2% had
EGFP expression in the notochord, 5% in the craniofacial cartilage, and no expression in
the ear (Table 14). Neither unit D nor unit E was sufficient to drive expression of the
EGFP reporter protein (Figure 13, 14). This suggests that when this DE regulatory region
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was split in half, and formed these D and E units, it eliminated important potential
transcription factors binding affinities.
Unlike the DE subunit, the reporter plasmids with the remaining R2 conserved
genomic sequence (AB, BC, CD, and EF) were not able to drive expression of the EGFP
reporter. The minimal R2 regulatory region was 120 bp in the DE region, and was
sufficient to drive expression of the reporter protein in most of the tissues that col2a1a
has been observed (Figure 6). These results reduce the functional transcriptional
regulation element region of R2 to 120 bp. Multiple stable transgenic lines were
generated with the DE transcriptional element regulating EGFP expression to confirm our
initial findings. I found that the stable R2-DE transgenic zebrafish expression was the
same as the full R2 stable transgenics (Figure 8). These results demonstrated the critical
region for driving col2a1a in the cartilage, notochord, and ear resided in the R2-DE
sequence.
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A

Zebrafish Chromosome 8

R2
Exon 1

Exon 2

Exon 3

1.7 kb
R2

B

GCCCTCTGACACCTGATGCCAATTGCGGTCAGTGTTTTGCTGGCGACACA
GATTCTTGTGCCAATGGCCAGGCCCCTCATCATCTGATCCGCAGCAACCC
AGCCACCCTACACACCCCTGGAGCCTCTCCGTGTTCTCCTCATCCCTCTAC
CTTTCCGCACTCTCCCTCCATCCACACCCGCGGCTCTCTTCTCCCCCACTG
CCCGGTGCTCTCTCACATTCCTCAGGTCTGCACACAGAGCCGCATTGTGTG
TGTGTCTTACAGAGCACACAGTCAGGGCTCATTTCGGACACACACACACA
TCCAACAGGGTGTGTGCACAGTCGCAGCGATGCGTACACACACATACACA
TATCCCT
C

Figure 1. R2 Regulatory Region Sequence and Results. (A) Schematic of the location of the R2
regulatory region on zebrafish chromosome 8. (B) Genomic sequence of R2 regulatory region.
(C) Injection of R2 driving expression of EGFP reporter gene, lateral view of zebrafish at 5dpf.
Table 4. Results of R2 injections.

R2

Date
Injected

Fish
Injected

3/20
2/28
Total

4
67
71

Notochord

Craniofacial
Cartilage

Ear

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

2
20
22

50%
30%
31%

2
17
19

50%
25%
27%

1
10
11

25%
15%
15%
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A
R2
Exon 1 Exon 2

A

B

C

AB

D

E

CD
BC

Exon 3

F
EF

DE
60 bp

B

R2

GCCCTCTGACACCTGATGCCAATTGCGGTCAGTGTTTTGCTGG
CGACACAGATTCTTGTGCCAATGGCCAGGCCCCTCATCATCTG
ATCCGCAGCAACCCAGCCACCCTACACACCCCTGGAGCCTCTC
CGTGTTCTCCTCATCCCTCTACCTTTCCGCACTCTCCCTCCATC
CACACCCGCGGCTCTCTTCTCCCCCACTGCCCGGTGCTCTCTCA
CATTCCTCAGGTCTGCACACAGAGCCGCATTGTGTGTGTGTCT
TACAGAGCACACAGTCAGGGCTCATTTCGGACACACACACAC
ATCCAACAGGGTGTGTGCACAGTCGCAGCGATGCGTACACAC
ACATACACATATCCCT

Figure 2. Minimization of R2 regulatory region. (A) Schematic depicting the dissection of the
R2 regulatory region, including 60 bp fragments and 120 bp overlapping fragments. (B)
Genomic sequence of R2 regulatory region with colors based on the smaller R2 fragments
(Blue-A; Red-B; Green-C; Purple-D; Orange-E; Yellow-F)
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Table 5. Results of zebrafish injected with R2-AB plasmid.

AB

Date
Injected

Fish
Injected

2/21
2/27
3/22
3/28
Total

17
36
34
146
233

Craniofacial
Cartilage

Notochord

Ear

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

1
0
0
0
1

6%
0%
0%
0%
0%

0
0
0
0
0

0%
0%
0%
0%
0%

1
0
0
0
1

6%
0%
0%
0%
0%

A

B

C

D

Figure 3. Results of R2-AB plasmid injections. No EGFP expression with R2-BC driving
expression. (A) Ventral view of craniofacial cartilage at 5 dpf. (B,C,D) Lateral view of
zebrafish head, mid-section, and trunk respectively at 5 dpf.
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Table 6. Results of zebrafish injected with R2-BC plasmid.

BC

Date
Injected

Fish
Injected

2/27
3/22
3/24
Total

34
45
112
191

Craniofacial
Cartilage

Notochord

Ear

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

0
0
0
0

0%
0%
0%
0%

0
1
1
2

0%
2%
1%
1%

0
0
1
1

0%
0%
1%
1%

A

B

C

D

Figure 4. Results of R2-BC plasmid injections. No EGFP expression with R2-BC driving
expression. (A) Ventral view of craniofacial cartilage at 5 dpf. (B,C,D) Lateral view of
zebrafish head, mid-section, and trunk respectively at 5 dpf.
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Table 7. Results of R2-CD driving expression of EGFP.

CD

Date
Injected

Fish
Injected

2/21
2/28
Total

117
33
191

Craniofacial
Cartilage

Notochord

Ear

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

0
0
0

0%
0%
0%

0
1
1

0%
3%
1%

0
0
0

0%
0%
0%

A

B

C

D

Figure 5. Results of R2-CD plasmid injections. No of EGFP expression with R2-CD driving
expression. (A) Ventral view of craniofacial cartilage at 5 dpf. (B,C,D) Lateral view of
zebrafish head, mid-section, and trunk respectively at 5 dpf.
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Table 8. Results of R2-DE driving expression of EGFP reporter gene.

DE

Date
Injected

Fish
Injected

2/21
2/27
2/28
Total

67
62
92
221

Notochord

Craniofacial
Cartilage

Ear

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

6
18
43
67

9%
29%
47%
30%

6
18
49
73

9%
29%
53%
33%

6
17
49
72

9%
27%
53%
33%

A

B

Figure 6. Results of R2-DE plasmid injections. EGFP present in craniofacial cartilage, ear,
and notochord. (A) Chondrocytes highlighted by EGFP expression in craniofacial cartilage.
Ventral view of zebrafish at 5 dpf. (B) Lateral view of zebrafish tail at 5 dpf depicting
expression of EGFP in notochord. (C) EGFP expression in craniofacial cartilage, ear, and
notochord visible in lateral view of zebrafish head at 5 dpf. (continued on next page) (D)
Zebrafish midsection at 5 dpf showing expression of EGFP in notochord.

39
C

D

Figure 6. (continued) Results of R2-DE plasmid injections. EGFP present in craniofacial
cartilage, ear, and notochord. (A) Chondrocytes highlighted by EGFP expression in
craniofacial cartilage. Ventral view of zebrafish at 5 dpf. (B) Lateral view of zebrafish tail at
5 dpf depicting expression of EGFP in notochord. (C) EGFP expression in craniofacial
cartilage, ear, and notochord visible in lateral view of zebrafish head at 5 dpf. (continued on
next page) (D) Zebrafish midsection at 5 dpf showing expression of EGFP in notochord.
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Table 9. Results of R2-EF driving expression of EGFP.
Craniofacial
Notochord
Date
Fish
Cartilage
EF

Ear

Injected

Injected

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

2/21
2/27
2/28
Total

41
22
46
109

0
0
1
1

0%
0%
2%
1%

1
1
0
2

2%
5%
0%
2%

0
0
0
0

0%
0%
0%
0%

A

B

C

D

Figure 7. Results of R2-EF plasmid injections. No of EGFP expression with R2-EF driving
expression. (A) Ventral view of craniofacial cartilage at 5 dpf. (B,C,D) Lateral view of
zebrafish head, mid-section, and trunk respectively at 5 dpf.
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A

B

Figure 8. Results of R2-DE stable line. EGFP expression in R2-DE stable line zebrafish. (A)
Ventral view of craniofacial cartilage at 5 dpf. (B) Lateral view of zebrafish craniofacial
cartilage with EGFP highlighting the chondrocytes.
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D

E

Figure 8. (continued) Results of R2-DE stable line. Images of the EGFP expression in the R2DE zebrafish stable line. (C) Lateral view of zebrafish head at 5 dpf. Expression of EGFP
present in the craniofacial cartilage, ear, pec fin. (D) 20x magnification of zebrafish ear
expressing reporter. (E) Lateral view of EGFP expression in the zebrafish notochord.
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Tissue Specificity of R2-DE Regulatory Region
The identification of the 120 bp col2a1a R2-DE regulatory region that
recapitulates the cartilage, ear, and notochord expression of the full R2 allows us to try
and determine what parts of this 120 bp sequence is critical for its tissue specificity. To
do this we divided the DE region into smaller fragments which will provided us with the
ability to dissect the tissue specificity in this regulatory unit. The DE unit was divided
into three fragments (Figure 9). The first regulatory fragment, D-E1, encompassed all of
D and the first 30 bp of the E region. Of the 131 embryos injected, the expression
plasmid driven by this fragment showed a decline in the expression level of the notochord
to 7% and ear expression was down to 8% (Figure 10). The craniofacial cartilage
expression was more than double compared to the other tissues, with expression of the
reporter protein in about 20% of the zebrafish. With the elimination of the last 30 bp of
the E regulatory region, the expression levels of the notochord and ear were decreased
(Table 10). The second regulatory fragment, D2-E, encompassed the last 30 bp of D
region and all of the E region. Two hundred and fifteen embryos were injected with the
D2-E reporter and subsequently scored for expression (Table 11). Of the zebrafish
embryos injected, about 25% of the zebrafish had fluorescence in the notochord, 62% in
the craniofacial cartilage, and 45% in the ear. Even though the notochord expression was
slightly lower than expected, the expression of the craniofacial cartilage and ear was
maintained with this 90 bp region (Figure 11). The third regulatory element consisting of
the center region of the DE region, D2-E1 (Figure 9). Even though the D2-E1 region was
minimized to only 60 bp, there continued to be EGFP expression in the craniofacial
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cartilage and ear similar to what was seen with the full R2-DE regulatory region (Table
12). The EGFP reporter protein was present in the craniofacial cartilage for about 49% of
the embryos injected and scored, and also expressed in the ear for about 25% of the
zebrafish (Figure 12). While expression in these two tissues was maintained, reporter
protein expression was completely lost in the notochord, which was down to only 3% of
the zebrafish.
The minimization of the DE region to 60 bp still maintained reporter fluorescence
in the tissues, which implied the regulatory element of col2a1a expression in the
craniofacial cartilage and ear is in the R2-D2-E1 sequence.
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A

60 bp
B
DE

GCGGCTCTCTTCTCCCCCACTGCCCGGTGCTCTCTCACATTC
CTCAGGTCTGCACACAGAGCCGCATTGTGTGTGTGTCTTAC
AGAGCACACAGTCAGGGCTCATTTCGGACACACACAC

Figure 9. Minimization of the R2-DE Sequence. (A) Schematic depicting where DE is located
in relation to R2 regulatory region, as well as the relative location of the minimized R2-DE
regions (D-E2; D2-E; D2-E1). (B) The sequence of the DE region. The gold sequence is the D
region, while the orange sequence is the E region. The D1 and the E1 region are bolded.
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D-E1

Table 10. Results of injections with D-E1 driving expression.
Craniofacial
Notochord
Date
Fish
Cartilage

Ear

Injected

Injected

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

3/27
3/28
Total

51
80
131

5
4
9

10%
5%
7%

15
11
26

29%
14%
20%

6
4
10

12%
5%
8%

A

B

C

Figure 10. Results of R2: D-E1 plasmid injections. (A) Ventral view of zebrafish head
depicting EGFP expression in the craniofacial cartilage. (B) Lateral view of the zebrafish head
showing faint expression in the craniofacial cartilage and ear of the zebrafish. (C) Lateral
view of zebrafish trunk with no EGFP expression (5 dpf).
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D2-E

Table 11. Results of injections with D2-E driving expression.
Craniofacial
Notochord
Date
Fish
Cartilage

Ear

Injected

Injected

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

3/27
3/28
4/4
5/29
Total

50
7
63
95
215

3
1
8
30
42

6%
14%
13%
32%
20%

19
2
40
73
134

38%
29%
63%
77%
62%

3
1
32
61
97

6%
14%
51%
64%
45%

A

B

C

Figure 11. Results of R2: D2-E plasmid injections. (A) Ventral view of zebrafish head
depicting EGFP expression in the craniofacial cartilage. (B) Lateral view of the zebrafish head
showing faint expression in the craniofacial cartilage and ear of the zebrafish. (C) Lateral
view of zebrafish trunk with EGFP expression (5 dpf).
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D2-E1

Table 12. Results of injections with D2-E1 driving expression.
Craniofacial
Notochord
Date
Fish
Cartilage

Ear

Injected

Injected

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

4/4
5/29
6/12
6/12
Total

140
196
198
161
695

9
5
2
3
19

6%
3%
1%
2%
3%

65
50
146
82
343

46%
26%
74%
51%
49%

57
27
70
22
176

41%
14%
35%
14%
25%

A

B

C

Figure 12. Results of R2: D2-E1 plasmid injections. (A) Ventral view of zebrafish head
depicting EGFP expression in the craniofacial cartilage. (B) Lateral view of the zebrafish head
showing faint expression in the craniofacial cartilage and ear of the zebrafish. (C) Lateral
view of zebrafish trunk with no EGFP expression in the notochord (5 dpf).
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D

Table 13. Results of injections with D region driving expression.
Craniofacial
Notochord
Date
Fish
Cartilage

Ear

Injected

Injected

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

3/20

5

0

0%

0

0%

0

0%

3/22
Total

39
44

0
0

0%
0%

0
0

0%
0%

0
0

0%
0%

A

B

C

Figure 13. Results of R2: D plasmid injections. (A) Ventral view of zebrafish head depicting
no EGFP expression in the craniofacial cartilage. (B) Lateral view of the zebrafish head
showing no expression in the craniofacial cartilage and ear of the zebrafish. (C) Lateral view
of zebrafish trunk with no EGFP expression in the notochord (5 dpf).
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E

Table 14. Results of injections with E region driving expression.
Date
Injected

Fish
Injected

3/27
Total

44
44

Craniofacial
Cartilage

Notochord

Ear

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

1
1

2%
2%

2
2

5%
5%

0
0

0%
0%

A

B

C

Figure 14. Results of R2: E plasmid injections. (A) Ventral view of zebrafish head depicting
no EGFP expression in the craniofacial cartilage. (B) Lateral view of the zebrafish head
showing no expression in the craniofacial cartilage and ear of the zebrafish. (C) Lateral view
of zebrafish trunk with no EGFP expression in the notochord (5 dpf).
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Identification of Transcription Factors Binding to Regulatory Region
It is well known that when one compares homologous regions of genomes from
related animals that the protein coding exons can be well conserved at rates upwards of
75% due in part to mutations in exons leading to non-functional proteins critical for
survival. Previous work has shown that there are regions of the genome not in exons that
seem to be conserved over evolution at rates similar to exons, suggesting that these noncoding DNA sequences are also critical for survival (Sakabe et al., 2012; ENCODE
Project Consortium, 2012). Many of these conserved non-coding DNA sequences have
been found to have required transcription factor binding sites that regulate gene
expression. We originally identified the R2 regulatory region by comparison of 12kb of
genomic sequence surrounding the transcriptional start site of col2a1a gene of various
teleost fish. Of the highly conserved sequences, the R2 region was able to recapitulate
most of the expression pattern of col2a1a in the cartilage, ear, and notochord. The
reduction of the R2 regulatory element determined that R2-DE was the most important
region for the regulation of this gene. A comparative genomics approach of teleosts was
again utilized but this time concentrated on short nucleotide sequences, which could
determine exactly which transcription factors are binding to these regions. Since the 120
bp DE region was sufficient to recapitulate the expression seen with the entire 360 bp R2
regulatory region, we focused on this region to be compared among four teleost fish:
medaka, stickleback, fugu, and zebrafish. Within the 120 bp sequence there were six
regions of highly conserved nucleotide sequences, with many of them located within the
D2-E1 region. Because of our focus on cartilage development we concentrated our
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analysis on the D2-E1 region. The conservation of these sequences suggested they were
the potential transcription factor binding sites regulating the expression of the col2a1a
gene. The preference of transcription factors to bind to specific sequences allowed for in
silico identification of potential proteins that would bind to the known conserved
sequence.
Using basic bioinformatic tools for identifying transcription factor binding sites, I
analyzed the R2-DE sequence. This resulted with a substantial amount of potential
transcription factor binding sites in this region. In order to filter through the results, I
focused on the three conserved regions completely in the D2-E1 sequence and analyzed
them using the JASPAR database to identify high scoring transcription factor binding
profiles that also where shown to play a role in cartilage formation. I used JASAR to
compare the conserved DNA sequence against known transcription factor binding
matrices. This allowed JASPAR to compute a relative score for putative candidates. The
closer the score is to 1, the higher the conservation/possible binding of the transcription
factors. The first highly conserved sequence, CATTCCTCAGGTC, is linked to the Ets
family of transcription factors with a relative score of 0.9160. The second highly
conserved sequence, TGCACACAGAG, was associated with the Runx family of
transcription factors with a relative score of 0.8137. The third highly conserved sequence,
ATTGTGTGTG, was associated with the Sox family of transcription factor with a
relative score of 0.8430. While JASPAR does suggest what exact transcription factor has
the best match to the analyzed sequence, we and others have found that these programs
tend to better identify families because of transcription factors being slightly flexible
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(transcription factor wobble) in what sequence they bind (Spitz and Furlong, 2012; Ko
and Engel, 1993). Based on the results of the database, Ets, Runx, and Sox transcription
factor families were potentially key regulators of the R2-D2E1 region. As previously
discussed, Runx2 and Sox9 transcription factors play an important role in chondrogenesis
in many animals (Flores et al., 2006; Yan et al., 2005). The identification of the specific
Ets transcription factor is more difficult to decipher because of the size of the family and
multiple members are expressed at the right time and place, but Fli1a was our primary
candidate based on its expression pattern in the pharyngeal arches at the appropriate
developmental stage.
Mutagenesis of Putative R2-DE Transcription Factor Binding Sites
I hypothesized that the R2-DE region contained transcription factor binding sites
for Fli1a, Sox9a, and Runx2b, and these transcription factors played important roles in
the regulation of col2a1a. This candidate gene approach was based off the current
literature and known expression patterns. The sequence logos generated by JASPAR
allowed us to identify nucleotides of the conserved genome sequences that must be
conserved for each transcription factor binding site, as well as locations of flexibility. We
next set out to mutate the key bases in our R2-DE EGFP reporter plasmids to determine if
our identified conserved sequences are necessary for R2-DE gene regulatory activity. By
using these mutated plasmids to generate transient transgenic reporter zebrafish a lack of
EGFP in the proper tissue would demonstrate the importance of the original sequence in
the binding of transcription factors.
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I first mutated the putative Ets-family binding site, from the core TTCC to GGAA
(Figure 16). The TTCC nucleotide sequence seemed to be particularly important for Ets
family member binding based on its sequence logo. Of the 280 fish injected, 75% of the
embryos had EGFP expression in the craniofacial cartilage and 59% showed expression
in the ear (Table 15). The notochord also had EGFP expression in about 33% present of
the embryos. The four nucleotides mutated did not seem to negatively affect the
expression level in the notochord or the cartilage (Figure 20), but potentially enhanced
expression. The mutagenized Runx-family binding site altered five nucleotides changing
the sequence from ACACAGA to GTCTAGC. Once again the expression levels of the
notochord and craniofacial cartilage were not affected in the 240 embryos injected
(Figure 17). Forty percent of the zebrafish expressed the reporter protein in the
notochord, and 33% expressed the protein in the craniofacial cartilage (Table 16)
comparable to normal R2-DE activity. The expression in the tissue of the ear was present
in about 16% of the zebrafish, which was slightly lower than the tissues of notochord and
craniofacial cartilage (Figure 21). The Sox-family core binding site was mutated from
TGTGT to CTCGG to prevent the family of transcription factors from binding (Figure
18). Similar to the other mutagenized plasmids described above, the notochord,
craniofacial cartilage, and ear expression levels of the Sox-family mutated binding site
remained steady (Figure 22). One hundred and seventy-eight embryos were injected with
this mutagenized plasmid and there was EGFP expression in the notochord of 45% of the
zebrafish, 51% in the craniofacial cartilage, and 25% of the ear (Table 17).
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The mutagenesis of the putative transcription factor binding sites individually did
not affect the expression level of EGFP in the cartilage, ear, and notochord tissues. This
was not surprising with the close proximity of these three conserved putative
transcription factor binding sites, and it is highly possible that protein-protein interactions
could still recruit the appropriate transcription factors, even with their inability to bind the
DNA anymore. Research by other groups has demonstrated that there are protein-protein
interactions between the Ets, Runx, and Sox family of transcription factors (Deramaudt et
al., 2001; Huang et al., 2009). To destabilize this putative three part regulation complex,
we next mutated different combinations of the three conserved binding sites. It was not
until two of the putative binding sites were mutated together, that a decrease in the
expression level of EGFP was seen in the tissues of interest. When the potential Sox and
Ets binding sites were mutated in conjunction with each other, the EGFP expression
levels were decreased in cartilage, notochord, and ear (Figure 23). Of the 311 embryos
injected, only 13% of the zebrafish expressed EGFP in the craniofacial cartilage and 5%
in the ear (Table 18). The zebrafish injected with the plasmid expressed the reporter
protein in the notochord for only 22 fish, or 7% of the zebrafish. Similar to these results,
the mutagenesis of the Ets and Runx binding sites also decreased the expression levels of
the reporter protein (Figure 24). The EGFP expression level in the notochord was only in
9% of zebrafish, 18% in the craniofacial cartilage, and 7% in the ear (Table 19).
By mutating these sequences of the potential binding sites we were able to disrupt the
effective binding of the transcription factors to the DNA, and in turn minimized the
likelihood of the R2-DE regulatory region to initiate transcription of the reporter gene.
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When the Runx and Sox binding sites were mutated in the plasmid, EGFP was present in
the notochord of 29% of fish, 31% in the craniofacial cartilage, and 11% in the ear
(Figure 25; Table 20). The percentage of zebrafish that expressed EGFP in the
appropriate tissues was not significantly decreased by the mutagenesis of the plasmids at
these two sites.
Increase Activity in Mutated Ets-family Binding Site
The percentage of zebrafish with expression in the craniofacial cartilage was
much higher for zebrafish injected with the plasmids mutated at the Ets binding site.
Initially in silico analysis and literature searches suggested the possibility of Ets1 binding
to the DE region, which was how the mutations were designed. Further analysis revealed
the possibility of Fli1a, an Ets family member, as a potential candidate also due to its
expressed in the correct tissue at the right time during development. A review of the Ets
mutagenesis revealed the transgenic reporter plasmids possibly contained a better binding
sequence for Fli1a. This finding was a potential explanation for the large percentage of
zebrafish that expressed EGFP in the craniofacial cartilage when injected with this
plasmid. The plasmid with the Ets mutated binding site seemed to up-regulate the
transcription of the reporter protein because it was better able to bind to the regulatory
region. In order to account for this, the mutation was repeated at the same site, but altered
to different nucleotides. The CATTCC sequence was mutated to TGCATG, which altered
the nucleotides to theoretically no longer allow the binding of Ets1 or Fli1a. Plasmids
were created in combination as well as alone. The Runx and Sox binding site mutations
remained the same from the previous mutagenesis. The plasmid with the Ets/Fli1a
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binding site mutated was injected into 410 zebrafish, and 66% expressed the reporter
protein in the craniofacial cartilage, 47% in the ear, and 36% percent in the notochord
(Figure 26; Table 21). Once again, the binding site mutation did not significantly
decrease the percentage of embryos that expressed EGFP. Similar to the previous
mutagenesis, when Fli1a and Runx binding sites were mutated simultaneously, it
decreased the percentage of zebrafish with reporter plasmid expression (Figure 27). There
were 677 zebrafish injected with this mutated plasmid; only 1% expressed the reporter
protein in the notochord, 3% in the craniofacial cartilage, and 5% in the ear (Table 22).
This data shows that the two mutations to the Ets family binding site, and the Ets binding
site in conjunction with the Runx site had very similar results. A change came with a
mutation to the Ets and Sox binding sites. The mutation to the Ets/Fli1a binding site,
together with the mutated Sox binding site, was injected into 168 zebrafish (Table 23).
Thirty nine percent of the zebrafish expressed the reporter protein in the craniofacial
cartilage, 15% in the notochord, and 18% in the ear (Figure 28). The initial mutation
decreased the amount of zebrafish expressing the reporter plasmid, but the new mutation
to the Ets/Fli1a and the Sox binding site did not have the same results.
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A

B

Figure 15. Sequence Conservation Schematic. Images depicting sequence conservation
and putative transcription factor binding sites. (A) The image is a comparison of
zebrafish and stickleback, but analysis also includes comparisons with tetradon and
medaka. There seems to be Ets, Runx, and Sox Transcription factor binding sites. (B)
Image of the binding sites based on the zebrafish genome, as well as the mutations that
were made to the sequence.
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D2

E1

…..TCTCTCACATTCCTCAGGTCTGCACACAGAGCCGCATTGTGTGTGTGTCTTACAGAGCACAC…

CATTCCTCAGGTC

CAGGAATCAGGTC

Ets1 Binding

Figure 16. Ets-Binding Site Mutation Schematic. The potential Ets binding site is
highlighted to show its location in the D2 region of DE. Based on the sequence logo,
mutations were made to alter the binding sequence to prevent the protein from binding.
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D2

E1

CCCGGTGCTCTCTCACATTCCTCAGGTC-TGCACACAGAGCCGCATTGTGTGTGTGTCTTACAGAGCA

TGCACACAGAG

TGCGTCTAGCG

Runx1 Binding

Figure 17. Runx-Binding Site Mutation Schematic. The region of DE highlighted is the
potential Runx binding site. The sequence logo for Runx provided the nucleotides that
are mutated to prevent binding of the transcription factor.
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D2

E1

E2

TC-TGCACACAGAGCCGCATTGTGTGTGTGTCTTACAGAGCACACAGTCAGGGCTCATTTCGGACACACA

ATTGTGTGTG

ATCTCGGGTG

Sox 9 Binding

Figure 18. Sox-Binding Site Mutation Schematic. The potential Sox binding site is
located in the E1 region of DE as depicted above. The sequence was mutated in
accordance to the sequence logo for Sox 9.
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D2

E1

…..TCTCTCACATTCCTCAGGTCTGCACACAGAGCCGCATTGTGTGTGTGTCTTACAGAGCACAC…

CATTCCTCAGGTC

TGCATGTCAGGTC

Fli1a Binding

Figure 19. Fli-Binding Site Mutation Schematic. After literature review and analysis of
the data, the original Ets binding site mutation may have provided a better Fli1a binding
site. More plasmids were created to mutate this potential Fli1a binding site according to
the sequence logo above.
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Mutation Ets

Table 15. Results of injections with DE plasmid containing Ets-binding site mutated.
Craniofacial
Notochord
Ear
Date
Fish
Cartilage
Injected

Injected

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

10/24
12/4
12/12
Total

146
51
83
280

41
17
33
91

28%
33%
40%
33%

103
43
64
210

71%
84%
77%
75%

87
35
43
165

60%
69%
52%
59%

A
A

B

C

A

A

Figure 20. Results of Injections with Ets Binding Site Mutated in Plasmid. Zebrafish at 5 dpf
depicting the EGFP expression pattern of Ets binding site mutated in the DE plasmid. (A)
Ventral view of craniofacial cartilage. Reflection of fluorescent protein may be visible in the
eye. (B) Lateral view of zebrafish head. EGFP present in craniofacial cartilage. (C) Lateral
view of trunk depicting the notochord (5dpf).
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Mutation Runx

Table 16. Results of injections with the Runx-binding site mutated in the DE plasmid.
Craniofacial
Notochord
Ear
Date
Fish
Cartilage
Injected

Injected

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

10/8
11/6
11/13
12/12
Total

28
23
82
107
240

7
9
21
60
97

25%
39%
26%
56%
40%

18
4
13
45
80

64%
17%
16%
42%
33%

4
3
7
24
38

14%
13%
9%
22%
16%

A
A

B

C

A

Figure 21. Results of Injections with Runx Binding Site Mutated in Plasmid. Zebrafish at 5
dpf depicting the EGFP expression pattern of Runx binding site mutated in the DE plasmid.
(A) Ventral view of zebrafish showing EGFP expression in the craniofacial cartilage. (B)
EGFP present in craniofacial cartilage and ear in lateral view of head. (C) Lateral view of the
notochord in the trunk region.
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Mutation Sox

Table 17. Results of injections of the DE plasmid with the Sox binding site mutated.
Craniofacial
Notochord
Ear
Date
Fish
Cartilage
Injected

Injected

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

10/24
11/20
12/3
Total

72
44
62
178

37
18
25
80

51%
41%
40%
45%

46
23
22
91

64%
52%
35%
51%

26
9
9
44

36%
20%
15%
25%

A
A

B

C

Figure 22. Results of Injections with Sox Binding Site Mutated in Plasmid. Images of
zebrafish at 5 dpf following injections of the DE plasmid with the Sox binding site mutated.
(A) Ventral view of craniofacial cartilage. (B) Lateral view of zebrafish head. (C) Lateral view
of zebrafish head, showing craniofacial cartilage and ear. (D) Lateral view of trunk to show
notochord.
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Mutation EtsSox

Table 18. Results of injections with Ets and Sox binding sites mutated in DE plasmid.
Craniofacial
Notochord
Ear
Date
Fish
Cartilage
Injected

Injected

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

10/17
11/7
11/21
Total

98
88
125
311

0
15
7
22

0%
17%
6%
7%

3
12
25
40

3%
14%
20%
13%

2
4
10
16

2%
5%
8%
5%

A

B

C

Figure 23. Results of Injections with Ets & Sox Binding Sites Mutated in Plasmid. Low or no
EGFP expression in zebrafish injected with mutated binding sites of Ets and Sox in DE
plasmid. (A) Ventral view of craniofacial cartilage at 5 dpf. (B, C) Lateral view of head and
trunk of zebrafish at 5 dpf.

67

Mutation EtsRunx

Table 19. Results of Ets and Runx binding sites mutated in DE plasmid injections.
Craniofacial
Notochord
Ear
Date
Fish
Cartilage
Injected

Injected

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

10/17
10/31
12/10
12/11
Total

36
211
10
107
364

3
17
2
12
34

8%
8%
20%
11%
9%

16
33
2
16
67

44%
16%
20%
15%
18%

6
12
1
6
25

17%
6%
10%
6%
7%

A

B

C

Figure 24. Results of Injections with Ets & Runx Binding Sites Mutated in Plasmid. Zebrafish
at 5 dpf, following injections of DE plasmid with Ets and Runx binding sites mutated. (A)
Ventral view of craniofacial cartilage. (B) Lateral view of zebrafish head. (C) Lateral view of
trunk to show notochord.
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Mutation RunxSox

Table 20. Results of Runx and Sox binding sites mutated in the DE plasmid.
Craniofacial
Notochord
Date
Fish
Cartilage

Ear

Injected

Injected

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

10/16
10/30
11/21
12/11
Total

9
93
113
78
293

5
30
25
25
85

56%
32%
22%
32%
29%

3
24
35
28
90

33%
26%
31%
36%
31%

1
10
13
8
32

11%
11%
12%
10%
11%

A

B

C

Figure 25. Results of Injections with Runx & Sox Binding Sites Mutated in Plasmid. Images
of zebrafish at 5 dpf depicting EGFP expression pattern. (A) Ventral view of craniofacial
cartilage. (B,C) Lateral view of zebrafish head and trunk, respectively.
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Mutation Fli

Table 21. Results of injections with Fli binding site mutated in the DE plasmid.
Craniofacial
Notochord
Date
Fish
Cartilage

Ear

Injected

Injected

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

4/16
4/17
4/24
4/30
Total

57
192
78
83
410

28
52
25
42
147

49%
27%
32%
51%
36%

41
118
52
60
271

72%
61%
67%
72%
66%

35
78
34
45
192

61%
41%
44%
54%
47%

A

B

C

Figure 26. Results of Injections with Fli Binding Site Mutated in Plasmid. EGFP expression
pattern in zebrafish with Fli binding site mutated. (A) Ventral view displaying the EGFP
expression in the chondrocytes of the craniofacial cartilage. (B) Lateral view of head to
display expression in the craniofacial cartilage and ear. (C) Lateral view of trunk to visualize
the notochord.
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Mutation FliRunx

Table 22. Results of injections with mutations in Fli and Runx binding site of DE.
Craniofacial
Notochord
Ear
Date
Fish
Cartilage
Injected

Injected

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

4/10
4/23
4/24
4/30
Total

331
186
116
44
677

4
0
1
1
6

1%
0%
1%
2%
1%

16
2
2
2
22

5%
1%
2%
5%
3%

14
15
3
1
33

4%
8%
3%
2%
5%

A

B

C

Figure 27. Results of Injections with Fli & Runx Binding Sites Mutated in Plasmid. No
expression of EGFP in the zebrafish at 5 dpf. (A) Ventral view of craniofacial cartilage. (B)
Lateral view of zebrafish head to show side view of craniofacial cartilage and ear. (C) Lateral
view of trunk to show lack of EGFP expression in the notochord.
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Mutation FliSox

Table 23. Results of DE plasmid with mutations in the Fli and Sox binding sites.
Craniofacial
Notochord
Ear
Date
Fish
Cartilage
Injected

Injected

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

# of GFP
Positive

% of GFP
Positive

5/2
5/22
Total

120
48
168

24
2
26

20%
4%
15%

65
0
65

54%
0%
39%

30
0
30

25%
0%
18%

A

B

C

Figure 28. Results of Injections with Fli & Sox Binding Sites Mutated in Plasmid. Images
depicting the EGFP expression in zebrafish injected with mutations to the Fli and Sox binding
sites of the DE plasmid. (A) Ventral view of zebrafish head at 5 dpf displaying craniofacial
cartilage. (B) Lateral view of zebrafish head to show expression in cartilage and ear. (C)
Lateral view of trunk to visualize the notochord.
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Identification of Transcription Factors
The identification of putative transcription factor binding sites was completed
using bioinformatic analysis, and this focused my research on the Ets, Sox, and Runx
families of transcription factors. We established the importance of the potential
transcription factor binding sites based on the decreased reporter expression with mutated
binding sites. Next we wanted to establish the exact member of the transcription factor
family that was bound to the R2-DE region using overexpression analysis. To do this, we
utilized RT-PCR to clone the zebrafish mRNA homologs for each of the candidate
transcription factor proteins into in vitro transcription vectors. This allowed us to produce
mRNA for each transcription factor to be injected into our R2-DE transgenic lines. These
RNAs were injected into the embryo at the one-cell stage resulting in the early production
of the transcription factors at a much earlier stage than normal in zebrafish. If the injected
proteins were indeed bound to the regulatory region, they could prematurely produce the
reporter protein that would be visible under fluorescence. The embryos of the stable line
of the R2 and R2-DE zebrafish were injected with the RNA of Fli1a, Sox9a, and Runx3
simultaneously in order to account for all of the theorized binding sites. As it can take up
to 2 hours for protein to be made from injected mRNA, we chose to test for reporter
activity from 6 to 10 hpf, which covers most of gastrulation but before somatogenesis
when col2a1a expression is first seen by in situ hybridization (Yan et al 1995). When the
injected embryos were inspected during gastrulation, the animal half of the embryo
appeared to be fluorescent green. Unfortunately, the uninjected embryos were inspected
they also appeared to have green fluorescence. There was an inability to distinguish
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between the injected and uninjected embryos. In order to determine whether the green
glow in the embryos was from EGFP or auto-fluorescence, an antibody was used to label
EGFP in the cells. Unfortunately, once again there was no discernable difference between
the injected and uninjected embryos because the fluorophore was present in both the
control and injected embryos (Figure 29). Future experiments would be necessary to
confirm the binding of the candidate transcription factors.
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A

B

C

Figure 29. Results of Transcription Factor Injections. Images of stable line embryo
injections with RNA of the transcription factors. Embryos stained with antibody for
EGFP expression. (A) Wild-type embryos injected with the RNA of Fli1a, Sox9a, and
Runx3. (B) Stable line of R2 embryos injected with the RNA of Fli1a, Sox9a, and
Runx3. (C) Stable line of DE embryos injected with the RNA of Fli1a, Sox9a, and
Runx3.

CHAPTER FOUR
DISCUSSION
Our experiments have identified the element of the R2 regulatory region that was
responsible for the transcriptional initiation of col2a1a. The minimization of this region
has allowed for the identification of specific transcription factor binding sites using
comparative genomics. Site-directed mutagenesis analysis demonstrated the importance
of those nucleotide sequences for the activity of R2, but it did not confirm the exact
member of the transcription factor family binding there. Even though candidate
transcription factors suspected to bind to these regions based on in silico analysis were
identified, future experiments would be necessary to confirm our results. Based on the
conserved nucleotide sequence Fli1a, Runx2b, and Sox9a were believed to bind to the
R2-DE regulatory element. Future experiments will be to confirm the hypothesis, and
whether the correct proteins of the transcription factor families were identified. This
confirmation could be accomplished by chromatin immunoprecipitation assay and or an
electromobility shift assay in order to confirm an interaction between the DNA sequence
and transcription factor proteins. This interaction confirmation would provide evidence
that the transcription factors are sufficient to drive expression of the col2a1a gene in
zebrafish. These experiments would confirm the DNA binding interactions, which leaves
the potential for future research to elucidate other protein-protein interactions in this
complex that are necessary for the regulation of col2a1a.
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The transcription factor binding sites we have focused on were identified based on
the cartilage expression present in the R2:D2-E1 region of the col2a1a gene. It was
interesting that the reporter plasmid with the entire DE region maintained expression in
the tissues specific to col2a1a expression, but once it was minimized to the D2-E1 unit
the notochord expression was lost. The loss of the first 30 bp and last 30 bp of the DE
region have eliminated reporter expression in the notochord, to show that there must have
been an important binding site for expression in this region. Notochord expression was
low with the D-E1 region, completely eliminated in the D2-E1 region, but present in 20%
of the embryos at the D2-E region. For this reason, I hypothesized there was an important
transcription factor binding site for notochord expression in the E2 region. Once again
comparative genomics and computer analysis could be used to identify the potential
transcription factor binding sites, which would demonstrate the sequence could be
important for notochord expression. Even though we have identified potential
transcription factor binding sites for cartilage expression, it would be compelling to see
which transcription factors differ in the notochord expression region. This process could
identify an enhancer element that is responsible for isolated expression in the notochord,
which would allow for transcriptional initiation in this specific tissue. This could be
appealing for many biomedical reasons because of the ability to drive expression of any
gene in a spatiotemporal manner with this enhancer sequence
Investigating the transcriptional regulation of zebrafish col2a1a gene entailed
identifying the components sufficient to drive expression of this gene. The paralogue of
this gene in zebrafish is col2a1b, which differs in its expression pattern based on in situ
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hybridization analysis (Dale and Topczewski, 2011), could be another interesting avenue
to explore. For example, col2a1a is present in the chondrocytes and the perichondrium of
the pharyngeal arches while col2a1b is restricted to the perichondrium. The experiments
completed on the regulation of col2a1a identified three potential transcription factor sites,
but because the homologues have some overlap in tissue specificity their regulatory
elements could be similar, especially if both paralogues were derived from an earlier gene
duplication that would have maintained a version of the col2a1a R2 element. Similar to
the process already completed, the identification of the regulatory element and
transcription factor binding sites could be achieved with comparative genomics. The
importance of transcription factor binding sites may again be confirmed with site-directed
mutagenesis on the reporter plasmids. This research would allow a comparison into how
the regulation of col2a1a and col2a1b has evolved.
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